By Ritu Kamal

This article is an excerpt from a blog post originally published on biodesignalumni.com

Ginger Graham delivered the 14th Annual Thomas Fogarty lecture this year, focusing on the changing landscape in healthcare innovation. Ms. Graham is the current President and CEO of Two Trees Consulting, the former President and CEO of Amylin Pharmaceuticals and the past Group Chairman of Guidant Corporation. She also serves on several boards, such as Proteus Digital Health, Genomic Health and Walgreens. With her extensive experience in both the pharmaceutical and medical device industries, Ms. Graham gave a thought-provoking talk that challenged conventional views on healthcare innovation.

Shifting Paradigms in Healthcare

Ms. Graham has spent the last 2 years gathering information about changes afoot in the healthcare industry from various sources, ranging from traditional healthcare providers and think tanks to entities with emerging healthcare interests, such as large retail operations. She collated insights from her research to highlight 5 major paradigm shifts (revolution in gene sequencing, retailization of healthcare, digital explosion, global middle class and healthcare policy changes) that are transforming healthcare in the U.S. and abroad, with implications for innovation in healthcare.

Click here for to read all of Ms. Graham’s thoughts on the changing healthcare landscape

Ritu Kamal is a former Stanford India Biodesign fellow and currently works for Roche Diagnostics in research and development.